Advanced search
Start date
Betweenand


Amitriptyline efficacy in decreasing implant-induced foreign body reaction

Full text
Author(s):
Show less -
Scheuermann, Karina ; Viana, Celso Tarso Rodrigues ; dos Reis, Diego Carlos ; de Lazari, Marcela Guimaraes Takahashi ; Orellano, Laura Alejandra Ariza ; Machado, Clara Tolentino ; dos Santos, Leticia Cristine Cardoso ; Ulrich, Henning ; Capettini, Luciano Santos Aggum ; Andrade, Silvia Passos ; Campos, Paula Peixoto
Total Authors: 11
Document type: Journal article
Source: IUBMB Life; v. N/A, p. 11-pg., 2023-04-22.
Abstract

Beyond its actions on the nervous system, amitriptyline (AM) has been shown to lower inflammatory, angiogenic, and fibrogenic markers in a few pathological conditions in human and in experimental animal models. However, its effects on foreign body reaction (FBR), a complex adverse healing process, after biomedical material implantation are not known. We have evaluated the effects of AM on the angiogenic and fibrogenic components on a model of implant-induced FBR. Sponge disks were implanted subcutaneously in C57BL/6 mice, that were treated daily with oral administration of AM (5 mg/ kg) for seven consecutive days in two protocols: treatment was started on the day of surgery and the implants were removed on the seventh day after implantation and treatment started 7 days after implantation and the implants removed 14 after implantation. None of the angiogenic (vessels, Vascular endothelial growth factor (VEGF), and interleukin-1 ss (IL-1 ss) or fibrogenic parameters (collagen, TGF-ss, and fibrous capsule) and giant cell numbers analyzed were attenuated by AM in 7-day-old implants. However, AM was able to downregulate angiogenesis and FBR in 14-day-old implants. The effects of AM described here expands its range of actions as a potential agent capable of attenuating fibroproliferative processes that may impair functionality of implantable devices. (AU)

FAPESP's process: 18/07366-4 - Purine and kinin receptors as targets of study and therapeutic interventions in neurological diseases
Grantee:Alexander Henning Ulrich
Support Opportunities: Research Projects - Thematic Grants